Multiparametric MRI for prediction of treatment response to neoadjuvant FOLFIRINOX therapy in borderline resectable or locally advanced pancreatic cancer

被引：0
|
作者：
Ji Hun Kang
Seung Soo Lee
Jin Hee Kim
Jae Ho Byun
Hyoung Jung Kim
Changhoon Yoo
Kyu-pyo Kim
Baek-Yeol Ryoo
Song Cheol Kim
机构：
[1] University of Ulsan College of Medicine,Department of Radiology and Research Institute of Radiology
[2] Asan Medical Center,Department of Radiology, Hanyang University College of Medicine
[3] Hanyang University Guri Hospital,Department of Oncology
[4] University of Ulsan College of Medicine,Department of Surgery
[5] Asan Medical Center,undefined
[6] University of Ulsan College of Medicine,undefined
[7] Asan Medical Center,undefined
来源：
European Radiology | 2021年 / 31卷
关键词：
Pancreatic neoplasms; Magnetic resonance imaging; Chemotherapy; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：864 / 874
页数：10
相关论文
共 50 条
  • [1] Multiparametric MRI for prediction of treatment response to neoadjuvant FOLFIRINOX therapy in borderline resectable or locally advanced pancreatic cancer
    Kang, Ji Hun
    Lee, Seung Soo
    Kim, Jin Hee
    Byun, Jae Ho
    Kim, Hyoung Jung
    Yoo, Changhoon
    Kim, Kyu-pyo
    Ryoo, Baek-Yeol
    Kim, Song Cheol
    EUROPEAN RADIOLOGY, 2021, 31 (02) : 864 - 874
  • [2] Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer
    Ferrone, Cristina R.
    Marchegiani, Giovanni
    Hong, Theodore S.
    Ryan, David P.
    Deshpande, Vikram
    McDonnell, Erin I.
    Sabbatino, Francesco
    Santos, Daniela Dias
    Allen, Jill N.
    Blaszkowsky, Lawrence S.
    Clark, Jeffrey W.
    Faris, Jason E.
    Goyal, Lipika
    Kwak, Eunice L.
    Murphy, Janet E.
    Ting, David T.
    Wo, Jennifer Y.
    Zhu, Andrew X.
    Warshaw, Andrew L.
    Lillemoe, Keith D.
    Fernandez-del Castillo, Carlos
    ANNALS OF SURGERY, 2015, 261 (01) : 12 - 17
  • [3] Neoadjuvant Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer
    Kovtun, K.
    Moser, J. A.
    Callery, M.
    Kent, T.
    Tseng, J.
    Miksad, R.
    Bullock, A.
    Schlechter, B.
    Mahadevan, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E198 - E198
  • [4] Neoadjuvant FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer: An intention to treat analysis
    Barenboim, Alex
    Lahat, Guy
    Geva, Ravit
    Nachmany, Ido
    Nakache, Richard
    Goykhman, Yaacov
    Brazowski, Eli
    Rosen, Galia
    Isakov, Ofer
    Wolf, Ido
    Klausner, Joseph M.
    Lubezky, Nir
    EJSO, 2018, 44 (10): : 1619 - 1623
  • [5] PROGNOSTIC FACTORS FOR PATIENTS WITH BORDERLINE RESECTABLE OR LOCALLY ADVANCED PANCREATIC CANCER RECEIVING NEOADJUVANT FOLFIRINOX
    Choi, Young Hoon
    Lee, Sang Hyub
    You, Min Su
    Paik, Woo Hyun
    Ryu, Ji Kon
    Kim, Yong-Tae
    GASTROENTEROLOGY, 2019, 156 (06) : S321 - S322
  • [6] Neoadjuvant FOLFIRINOX for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis
    Choi, Jin G.
    Nipp, Ryan D.
    Tramontano, Angela
    Ali, Ayman
    Zhan, Tiannan
    Pandharipande, Pari
    Dowling, Emily C.
    Ferrone, Cristina R.
    Hong, Theodore S.
    Schrag, Deborah
    Fernandez-Del Castillo, Carlos
    Ryan, David P.
    Kong, Chung Yin
    Hur, Chin
    ONCOLOGIST, 2019, 24 (07): : 945 - 954
  • [7] Prognostic Factors for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer Receiving Neoadjuvant FOLFIRINOX
    Choi, Young Hoon
    Lee, Sang Hyub
    You, Min Su
    Shin, Bang Sup
    Paik, Woo Hyun
    Ryu, Ji Kon
    Kim, Yong-Tae
    Kwon, Wooil
    Jang, Jin-Young
    Kim, Sun-Whe
    GUT AND LIVER, 2021, 15 (02) : 315 - 323
  • [8] Treatment of pancreatic cancer-neoadjuvant treatment in borderline resectable/locally advanced pancreatic cancer
    Scheufele, Florian
    Hartmann, Daniel
    Friess, Helmut
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 4
  • [9] Neoadjuvant Treatment in Locally Advanced and Borderline Resectable Pancreatic Cancer vs Primary Resectable Pancreatic Cancer
    Del Chiaro, Marco
    Valente, Roberto
    Arnelo, Urban
    JAMA SURGERY, 2017, 152 (11) : 1057 - 1057
  • [10] Survival in borderline resectable and locally advanced pancreatic cancer is determined by the duration and response of neoadjuvant therapy
    Wijetunga, Asanka R.
    Chua, Terence C.
    Nahm, Christopher B.
    Pavlakis, Nick
    Clarke, Stephen
    Chan, David L.
    Diakos, Connie
    Maloney, Sarah
    Ashrafi-Zadeh, Amir
    Kneebone, Andrew
    Hruby, George
    Jamieson, Nigel B.
    Gill, Anthony
    Mittal, Anubhav
    Samra, Jaswinder S.
    EJSO, 2021, 47 (10): : 2543 - 2550
12345